KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Tax Assets Current Leases Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

West Pharmaceutical Services (WST) Raw Materials (2017 - 2018)

Historic Raw Materials for West Pharmaceutical Services (WST) over the last 5 years, with Q4 2018 value amounting to $90.4 million.

West Pharmaceutical Services' Raw Materials rose 203.16% to $90.4 million in Q4 2018 from the same period last year, while for Dec 2018 it was $90.4 million, marking a year-over-year increase of 203.16%. This contributed to the annual value of $90.4 million for FY2018, which is 203.16% up from last year.
Per West Pharmaceutical Services' latest filing, its Raw Materials stood at $90.4 million for Q4 2018, which was up 203.16% from $88.6 million recorded in Q4 2017.
In the past 5 years, West Pharmaceutical Services' Raw Materials ranged from a high of $90.4 million in Q4 2018 and a low of $88.6 million during Q4 2017